Real-World Data on Empagliflozin and Dapagliflozin Use in Patients with HEART Failure: The RED–HEART Study

The RED-HEART study provided comprehensive real-world data about implementing SGLT2is in patients with HF. These results suggest that there is a need for organized action and close collaboration between healthcare providers to improve the implementation of SGLT2is, especially in patients with HF with preserved ejection fraction and chronic kidney disease.

Authors

Institutions

Publication Details

Journal
ESC Heart Failure
Published
2024-09-28
DOI
https://doi.org/10.1002/ehf2.15049
Citations
18
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
6.44
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Data on Empagliflozin and Dapagliflozin Use in Patients with HEART Failure: The RED–HEART Study

Mustafa Yenerçağ, Mehmet Kaplan, Selda Murat, Umut Karabulut et al.
18 citations
ESC Heart Failure
Diabetes Treatment and Management
6.44
article

Real-World Data on Empagliflozin and Dapagliflozin Use in Patients with HEART Failure: The RED–HEART Study

Mustafa Yenerçağ, Mehmet Kaplan, Selda Murat, Umut Karabulut, Dilay Karabulut, Cihan Altın, Murat Çaylı, Ersan Oflar, Tarık Kıvrak, Fahri Çakan, Ersin Kaya, İbrahim Halil Özdemir, Ümit Yaşar Si̇nan, Gülsüm Meral Yılmaz Öztekin, Mustafa Doğduş, Umut Kocabaş, Işıl Ergin, Sinem Çakal, Uğur Önsel Türk, Emre Özçalık, Fatma Özge Salkın, Veysel Yavuz, Cennet Yıldız, Taner Şen, Şeyda Günay Polatkan
article en
18 citations

Abstract

The RED-HEART study provided comprehensive real-world data about implementing SGLT2is in patients with HF. These results suggest that there is a need for organized action and close collaboration between healthcare providers to improve the implementation of SGLT2is, especially in patients with HF with preserved ejection fraction and chronic kidney disease.

ESC Heart FailureVol. 12(1)
Bursa Uludağ Üni̇versi̇tesi̇ (TR), Izmir University (TR), Fırat University (TR), İzmir University of Economics (TR), State Hospital (GB), Kütahya Dumlupınar Üniversitesi (TR), Ege University (TR), Eskişehir City Hospital (TR), Chest Diseases Hospital (KW), Haseki Eğitim ve Araştırma Hastanesi (TR), Antalya Eğitim ve Araştırma Hastanesi (TR), Istanbul University-Cerrahpaşa (TR), Samsun University (TR), Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi (TR), Sağlık Bilimleri Üniversitesi (TR), Istanbul Eye Hospital (TR), Setas (Turkey) (TR), Manor Hospital (GB), Kutahya Saglik Bilimleri Universitesi, Seyhan Devlet Hastanesi, Eskişehir Osmangazi University (TR), Gaziantep University (TR), Istanbul University (TR), University of Health Sciences Antigua (AG)
No poverty
Openalex Percentile: Top 3%
Diabetes Treatment and Management
6.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.